Associated Papers
Succinate dehydrogenase variants in paraganglioma: why are B subunit variants 'bad'?
Gruber LM et al.
Endocrine Oncology (bristol, England), 2023
37434649 (PubMed )
Supplement: supplementary_table_1.xlsx › Truncating_Variants
Two Na+ Sites Control Conformational Change in a Neurotransmitter Transporter Homolog.
Tavoulari S et al.
The Journal of Biological Chemistry, 2016
An additional substrate binding site in a bacterial phenylalanine hydroxylase.
Ronau JA et al.
European Biophysics Journal : Ebj, 2013
The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
Burnichon N et al.
The Journal of Clinical Endocrinology and Metabolism, 2009
Mutations associated with succinate dehydrogenase D-related malignant paragangliomas.
Timmers HJ et al.
Clinical Endocrinology, 2008
The use of forced protein evolution to investigate and improve stability of family 10 xylanases. The production of Ca2+-independent stable xylanases.
Andrews SR et al.
The Journal of Biological Chemistry, 2004
Select a paper to view details